i cant wait for October 1 when this ting is still under .20 and we will be rid of your incessant blabber on this MB. remember that bet RR?
lympro is promising? please do tell me why. all i have seen so far is subpar data and a failure to gather enough subjects for a simple study.
thanks for the lulz SNT. have you checked the fiscal requirements for uplist? how many does AMBS meet, even after a hefty R/S? Which market will they uplist to? One that doesnt require any revenues (since AMBS has none)? The strong exchanges require $$$$. They could always list to standard 4 in AMEX. That sounds AWESOME
your argument is a lemmings argument. because one lemming jumps off a cliff and all the other follow, it must have been a good idea to jump off the cliff huh?
i am in for the same reasons, the science. not the BoD. many companies fail even with the best directors (or perceived best). Look at JP Morgan and Enron
is that why they couldnt get enough people to do the 002 study before C4CT? because they are very competent? seems to me that a competent group would have had the study completed and not lied to us up until C4CT. i look forward to your explanation............
purely speculation nord. I dont know how you can be "reasonably sure" when you have no data to back it up
it leads me to beleive we will have more delays and dirt kicking - they havent even enrolled enough people for the next study for LymPro - how are you going to commercialize by EoY? Hogwash
and more overhead. we need to get a study finished before we get all giddy about more people on the team. O wait, whats that you say? we have a BILLION shares with which to pay these guys? OK, good, nevermind then, please carry on